PMV Pharmaceuticals Inc. (PMVP)
PMV Pharmaceuticals Statistics
Share Statistics
PMV Pharmaceuticals has 51.93M shares outstanding. The number of shares has increased by 0.95% in one year.
| Shares Outstanding | 51.93M |
| Shares Change (YoY) | 0.95% |
| Shares Change (QoQ) | 0.36% |
| Owned by Institutions (%) | 75.54% |
| Shares Floating | 43.79M |
| Failed to Deliver (FTD) Shares | 129 |
| FTD / Avg. Volume | 0.1% |
Short Selling Information
The latest short interest is 1.38M, so 2.66% of the outstanding shares have been sold short.
| Short Interest | 1.38M |
| Short % of Shares Out | 2.66% |
| Short % of Float | 3.16% |
| Short Ratio (days to cover) | 7.73 |
Valuation Ratios
The PE ratio is undefined and the forward PE ratio is -0.84. PMV Pharmaceuticals's PEG ratio is undefined.
| PE Ratio | undefined |
| Forward PE | -0.84 |
| PS Ratio | 0 |
| Forward PS | 0.4 |
| PB Ratio | 0.44 |
| P/FCF Ratio | undefined |
| PEG Ratio | undefined |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for PMV Pharmaceuticals Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.22, with a Debt / Equity ratio of undefined.
| Current Ratio | 12.22 |
| Quick Ratio | 12.22 |
| Debt / Equity | undefined |
| Total Debt / Capitalization | 0.67 |
| Cash Flow / Debt | -43.09 |
| Interest Coverage | undefined |
Financial Efficiency
Return on equity (ROE) is -0.33% and return on capital (ROIC) is -37.83%.
| Return on Equity (ROE) | -0.33% |
| Return on Assets (ROA) | -0.31% |
| Return on Capital (ROIC) | -37.83% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1,249,127.66 |
| Employee Count | 47 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -16.1M |
| Effective Tax Rate | 0.22 |
Stock Price Statistics
The stock price has increased by -38.76% in the last 52 weeks. The beta is 1.45, so PMV Pharmaceuticals's price volatility has been higher than the market average.
| Beta | 1.45 |
| 52-Week Price Change | -38.76% |
| 50-Day Moving Average | 1.34 |
| 200-Day Moving Average | 1.51 |
| Relative Strength Index (RSI) | 25.04 |
| Average Volume (20 Days) | 127.66K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -85.45M |
| Net Income | -58.71M |
| EBITDA | -85.45M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.14 |
Balance Sheet
The company has 40.88M in cash and 1.19M in debt, giving a net cash position of 39.69M.
| Cash & Cash Equivalents | 40.88M |
| Total Debt | 1.19M |
| Net Cash | 39.69M |
| Retained Earnings | -368.71M |
| Total Assets | 191.29M |
| Working Capital | 161.29M |
Cash Flow
In the last 12 months, operating cash flow was -51.28M and capital expenditures -655K, giving a free cash flow of -51.94M.
| Operating Cash Flow | -51.28M |
| Capital Expenditures | -655K |
| Free Cash Flow | -51.94M |
| FCF Per Share | -1.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PMVP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -104.59% |
| FCF Yield | -91.75% |
Analyst Forecast
The average price target for PMVP is $5, which is 358.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $5 |
| Price Target Difference | 358.7% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Scores
| Altman Z-Score | -0.79 |
| Piotroski F-Score | 1 |